References to Primary Literature
- Hickey DMB, Benson GM Bile Acid Sequestrants: Recent Patent Applications. Curr. Opin. Thera. Patents 1992 2 1 78–81.
- Bergstrom JD The Zaragozic Acids: Potent Natural Product Derived Inhibitors of Squalene Synthase and Cholesterol Synthesis. XI International Symposium on Drugs Affecting Lipid Metabolism Florence, Italy 1992, 120 Abstracts.
- McCarthy AD Squalene Synthetase Inhibition: Effects of a Novel Natural Product on Cholesterol Metabolism. XI International Symposium on Drugs Affecting Lipid Metabolism Florence, Italy 1992, 120 Abstracts.
- Lenaers A, Breugnot C, Privat S, Guillonneaun C, Regnier G, Vilaine JP A Novel and Potent Inhibitor of Low Density Lipoprotein Peroxidation In Vitro and In Vivo.. XI International Symposium on Drugs Affecting Lipid Metabolism Florence, Italy 1992, 82.
References to Patent Literature
- Merck & Co, EP-408806-A.
- Rhone-Poulenc Rorer, US4996234.
- Warner-Lambert Co, EP-409281-A.
- Tanabe Seiyaku Co Ltd, EP-420266-A.
- E R Squibb & Sons Inc, EP-444532-A.
- Bristol-Myers Squibb Co, EP-476493-A.
- Bristol-Myers Squibb Co, EP-482342-A.
- Rhone-Poulenc Sante, WO9109021.
- Mitsubishi Kasei Corp, EP-439059-A.
- Warner-Lambert Co, US5030653.
- Pfizer Inc, EP-418071-A.
- Fujirebio Inc, EP-421441-A.
- Symphar, SA, EP-418064-A.
- Merck & Co, US5102907.
- Merrell Dow Pharm Inc, EP-468457-A.
- Merrell Dow Pharm Inc, WO9114668.
- Merck & Co, US4996231.
- Merck & Co, US4983597.
- Suntory Ltd, EP-475214-A.
- Wellcome Foundation Ltd, WO9203130.
- Steigerwald A G, EP-458287-A.
- Ciba-Geigy AG, EP-475895-A.
- Ciba-Geigy AG, EP-434621-A.
- Ciba-Geigy Corp, US5003070.
- Astra A B, WO9113615.
- Hoechst A G, EP-450588-A.
- Adir & Co, EP-463945-A.
- Adir & Co, EP-479631-A.
- Beecham Group plc, WO9202520.
- Beecham Group plc, EP-415605-A.
- Beecham Group plc, EP-419035-A.
- Pfizer Inc, WO9103474.
- Sankyo Co Ltd, EP-441605-A.
- Pfizer Inc, WO9119702.
- Upjohn Co, WO9112799.
- Mochida Pharm Co Ltd, EP-444546-A.